Sight Sciences, Inc. (SGHT) Dividend History

Sight Sciences, Inc. (SGHT) is a medical technology company focused on developing innovative devices and solutions for treating eye conditions, particularly those related to the anterior segment, such as glaucoma and other ocular diseases. The company's products aim to improve patient outcomes through minimally invasive procedures and advanced ocular diagnostics.

4040 Campbell Ave,, Menlo Park, CA, 94025
Phone: (415) 889-0550
Website: https://www.sightsciences.com

Dividend History

Sight Sciences, Inc. currently does not pay dividends

Company News

  • The global dry eye treatment devices market is expected to reach $898.78 million by 2033, driven by the increasing prevalence of dry eye disease and the development of innovative treatment options. The market is seeing a shift towards more sophisticated devices that offer targeted therapies, such as the LipiFlow System and iLux Device for treating meibomian gland dysfunction, and the trueTear intranasal neurostimulation device for stimulating tear production.

    GlobeNewswire Inc.
    Featured Companies: JNJ
  • Sight Sciences CFO Alison Bauerlein sold over $65,000 worth of company stock to cover tax liabilities from vesting of restricted stock units. The company has reported positive developments in its trials and modest revenue growth, but also faces challenges with profitability.

    Investing.com
  • Sight Sciences (SGHT) delivered earnings and revenue surprises of -13.79% and 5.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: STE
  • Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers ARB IOT Group Limited (NASDAQ: ARBB) shares rose 270% to $3.4850 after gaining around 18% on Friday. IMAC Holdings, Inc. (NASDAQ: BACK) shares jumped 108% to $5.05 after jumping 53% on Friday. Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) jumped 75% to $2.0988 after the company announced 95% accuracy results for HYLA blood sensor. Gracell Biotechnologies Inc. (NASDAQ: GRCL) shares gained 60.3% to $9.92 after AstraZeneca announced plans to buy Gracell Biotechnologies for up to $1.2 billion. Science 37 Holdings, Inc. (NASDAQ: SNCE) jumped 52% to $6.62. Science 37 Holdings got notification from Nasdaq indicating the company regained compliance with minimum closing bid price requirement for continued listing. Volcon, Inc. (NASDAQ: VLCN) rose 49.8% to $0.1483 after jumping around 24% on Friday. Sight Sciences, Inc. (NASDAQ: SGHT) gained 48.9% to $5.42. AERWINS Technologies Inc.(NASDAQ: AWIN) gained 36.4% to $0.1637 after the company entered into a letter of intent to form an entity with Helicopter Technology. The company will own 70% and Helicopter Technology will own 30%. SCWorx Corp. (NASDAQ: WORX) rose 32% to $2.3349 after the company announced that it signed a definitive agreement and plan of merger with American Environmental Partners. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) gained 30% to $1.1750 after the company announced IRB approval of its Phase IIA clinical study ...

    Benzinga
  • Apple, WestRock and Oracle are the stocks in the spotlight Tuesday.

    MarketWatch
    Featured Companies: AAPL BRK.A CASY CGC GDDY M NVDA OFIX ORCL WEED ZION
Page data last updated 07/24/2025 01:03:52 UTC